Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03372109 · ClinicalTrials.gov registry record · NA

Evaluate the Effects of Repeated Periods of Modified Fasting to Support Healthy Natural Weight Management and Prevention of Weight Gain

A NA study of Body Weight Changes, sponsored by Supplement Formulators.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT03372109: Completed NA study of Body Weight Changes, sponsored by Supplement Formulators.

NCT03372109 is a NA study of Body Weight Changes that has completed, run by Supplement Formulators. The registered enrollment target is 23 participants, below the 70-participant average among 11 other Body Weight Changes trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03372109, a NA study of Body Weight Changes, has completed, sponsored by Supplement Formulators.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the effects of repeated periods of modified fasting in support of healthy weight management and prevention of weight gain over the winter holiday period (mid-November to early January) in comparison to regular diet and activity.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Meal replacement shake
  • DIETARY_SUPPLEMENT Multivitamin and mineral capsules
  • DIETARY_SUPPLEMENT Fish oil with sesame lignans and olive extract softgel
  • DIETARY_SUPPLEMENT Prebiotic Chewable tablet
  • DIETARY_SUPPLEMENT Clove Extract and Maqui Berry extract capsule

Study Locations (1)

Florida

  • Life Extension Clinical Research, Inc. - Fort Lauderdale

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2017-11-14
Est. Completion 2018-03-22
Phase NA
Supplement Formulators

14 total trials

What the finished NCT03372109 record still lists

NCT03372109 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 70-participant average among 11 other Body Weight Changes trials with a reported enrollment target (67% lower).

The record links to 1 condition, with Body Weight Changes appearing as the primary indexed condition, and to 5 interventions - of which Meal replacement shake is the first listed.

NCT03372109 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT03372109 about?

NCT03372109 is a clinical study titled "Evaluate the Effects of Repeated Periods of Modified Fasting to Support Healthy Natural Weight Management and Prevention of Weight Gain". The purpose of this study is to assess the effects of repeated periods of modified fasting in support of healthy weight management and prevention of weight gain over the winter holiday period (mid-November to early January) in comparison to regular diet and activity.

What is the current status of trial NCT03372109?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2017-11-14. Estimated completion is 2018-03-22.

What conditions does trial NCT03372109 study?

This clinical trial studies the following conditions: Body Weight Changes.

What interventions are being tested in trial NCT03372109?

The interventions under investigation include: Meal replacement shake (DIETARY_SUPPLEMENT), Multivitamin and mineral capsules (DIETARY_SUPPLEMENT), Fish oil with sesame lignans and olive extract softgel (DIETARY_SUPPLEMENT), Prebiotic Chewable tablet (DIETARY_SUPPLEMENT), Clove Extract and Maqui Berry extract capsule (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03372109?

This trial is sponsored by Supplement Formulators, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03372109 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Weight Changes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03372109's enrollment target sits among peer trials

23 11th of 11 higher than 1 of 11 other Body Weight Changes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Body Weight Changes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03372109, the US trial registry maintained by the National Library of Medicine. NCT03372109 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.